In this study, we investigated whether plasma exosomal HMGB1 in patients with ESCC was an indicator of the radiotherapy response and the role of irradiation (IR)-induced exosomal HMGB1 in radioresistance. The gene discussed is HMGB1; the disease is esophageal squamous cell carcinoma.